The Use of Clinically Approved Small Particles of Iron Oxide (SPIO) for Labeling of Mesenchymal Stem Cells Aggravates Clinical Symptoms in Experimental Autoimmune Encephalomyelitis and Influences Their In Vivo Distribution

  • Richard Schäfer, Miriam Ayturan, Rüdiger Bantleon, Rainer Kehlbach, Joerg Pintaske, Sabine Conrad, Hartwig Wolburg, Jakub Wiskirchen, Robert Weissert
  • Cell Transplantation, August 2008, SAGE Publications
  • DOI: 10.3727/096368908786576480

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Robert Weissert